Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Nexgel Inc (NXGL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/11/2025: NXGL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $6
1 Year Target Price $6
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.12% | Avg. Invested days 27 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/11/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 20.59M USD | Price to earnings Ratio - | 1Y Target Price 6 |
Price to earnings Ratio - | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta 0.52 | 52 Weeks Range 2.00 - 5.10 | Updated Date 07/13/2025 |
52 Weeks Range 2.00 - 5.10 | Updated Date 07/13/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.45 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -30.7% | Operating Margin (TTM) -27.69% |
Management Effectiveness
Return on Assets (TTM) -20.77% | Return on Equity (TTM) -60.08% |
Valuation
Trailing PE - | Forward PE 41.84 | Enterprise Value 22139939 | Price to Sales(TTM) 2.01 |
Enterprise Value 22139939 | Price to Sales(TTM) 2.01 | ||
Enterprise Value to Revenue 2.16 | Enterprise Value to EBITDA -0.85 | Shares Outstanding 7654540 | Shares Floating 6447417 |
Shares Outstanding 7654540 | Shares Floating 6447417 | ||
Percent Insiders 16.2 | Percent Institutions 8.56 |
Upturn AI SWOT
Nexgel Inc
Company Overview
History and Background
Nexgel, Inc. was founded to develop and commercialize advanced hydrogels for various applications. While specific founding year and early milestones are unavailable from public sources, the company has focused on developing proprietary hydrogel technology for consumer and healthcare markets.
Core Business Areas
- Advanced Hydrogels: Develops and manufactures advanced hydrogels, focusing on performance and skin health.
- Consumer Healthcare: Creates and markets hydrogel-based products in the consumer healthcare space, including skincare and wound care.
- Private Label Manufacturing: Offers private label manufacturing services for other companies seeking to incorporate hydrogel technology into their products.
Leadership and Structure
Public information on Nexgel Inc.'s leadership and organizational structure is limited, hindering a full detailed description.
Top Products and Market Share
Key Offerings
- Hydra-Lock Moisturizing Gel: A flagship product designed for superior moisturization and skin hydration. Market share data is not publicly available. Competitors include Neutrogena Hydro Boost, and other major skincare brands offering hydrating gels and creams. Revenue and number of users is not publicly available.
- Advanced Wound Care Gel: A hydrogel-based wound care product designed to promote healing and reduce scarring. Market share data is not publicly available. Competitors include Curad, Band-Aid, and other brands providing wound care solutions. Revenue and number of users is not publicly available.
Market Dynamics
Industry Overview
The advanced hydrogel market is growing, driven by increasing demand in healthcare, cosmetics, and other applications. Factors like aging populations, increasing awareness of advanced wound care, and rising demand for advanced skincare solutions are driving the market. However, there is fierce competition among brands already in the market, and this competition may be a factor in the company's recent underperformance.
Positioning
Nexgel positions itself as an innovator in advanced hydrogel technology, aiming to create high-performance products for consumer healthcare and private label partners. Nexgel is focused on skin health and enhanced product performance via its hydrogels.
Total Addressable Market (TAM)
The global hydrogel market is estimated to reach billions of dollars. Nexgel is positioned to capture a share of this market by focusing on niche applications with its hydrogel technology. The TAM is large but Nexgel's current market share is small, providing opportunity for growth if they are able to capture market share.
Upturn SWOT Analysis
Strengths
- Proprietary hydrogel technology
- Focus on skin health and enhanced product performance
- Potential for private label manufacturing partnerships
- Innovative formulations
Weaknesses
- Limited brand recognition compared to established players
- Restricted financial resources compared to larger competitors
- Dependence on private label manufacturing success
- Lack of information available on key metrics like Revenue, market share, number of users, etc
Opportunities
- Expanding into new product categories (e.g., sun care, anti-aging)
- Securing strategic partnerships with larger healthcare or consumer goods companies
- Leveraging e-commerce channels for direct-to-consumer sales
- Growing applications in the wound care sector
Threats
- Intense competition from established players with greater resources
- Changes in consumer preferences and market trends
- Regulatory hurdles and compliance costs
- Potential for technological obsolescence
Competitors and Market Share
Key Competitors
- JNJ
- NSRGY
- UNVRF
Competitive Landscape
Nexgel's competitive advantages stem from its proprietary hydrogel technology. However, its size and brand recognition are significant disadvantages compared to larger competitors like Johnson & Johnson (JNJ) and Nestle (NSRGY).
Growth Trajectory and Initiatives
Historical Growth: Historical growth is unknown due to the lack of financial data.
Future Projections: Future growth projections are unavailable due to the lack of analyst estimates.
Recent Initiatives: Recent strategic initiatives may include new product launches or new partnerships, but it is not possible to assess without further information.
Summary
Nexgel is a small company with innovative hydrogel technology but faces significant competition. Their strength lies in their proprietary formulations, however their lack of financial backing and limited market presence pose major challenges. To improve, Nexgel needs to find additional ways to generate revenue. If they can, this will turn Nexgel into a successful company.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company press releases
- Industry reports
- Publicly available information
- Analyst reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is estimated and may not be precise. Financial data is incomplete and requires further data to be complete.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Nexgel Inc
Exchange NASDAQ | Headquaters Langhorne, PA, United States | ||
IPO Launch date 2021-12-22 | CEO, President & Director Mr. Adam R. Levy | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 19 | Website https://nexgel.com |
Full time employees 19 | Website https://nexgel.com | ||
NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.